Depression and health outcomes in refractory epilepsy.

Trial Profile

Depression and health outcomes in refractory epilepsy.

Phase of Trial: Phase III

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Sertraline (Primary)
  • Indications Depression; Epilepsy; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 22 Apr 2009 Results reported at AAN 2009.
    • 24 Mar 2009 Actual patient number (140) added as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top